These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32312333)

  • 1. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.
    Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M
    Br J Nutr; 2020 Aug; 124(4):450-456. PubMed ID: 32312333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial.
    Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M
    Complement Ther Med; 2020 Jun; 51():102428. PubMed ID: 32507439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial.
    Dorosti M; Jafary Heidarloo A; Bakhshimoghaddam F; Alizadeh M
    Br J Nutr; 2020 Feb; 123(3):328-336. PubMed ID: 31685037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA; Khan DA; Ijaz A; Khan S
    Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.
    Mofidi F; Poustchi H; Yari Z; Nourinayyer B; Merat S; Sharafkhah M; Malekzadeh R; Hekmatdoost A
    Br J Nutr; 2017 Mar; 117(5):662-668. PubMed ID: 28345499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Cheraghpour M; Imani H; Ommi S; Alavian SM; Karimi-Shahrbabak E; Hedayati M; Yari Z; Hekmatdoost A
    Phytother Res; 2019 Aug; 33(8):2118-2125. PubMed ID: 31264313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease.
    Cerletti C; Colucci M; Storto M; Semeraro F; Ammollo CT; Incampo F; Costanzo S; De Bartolomeo G; Portincasa P; Barone M; Di Castelnuovo A; Semeraro N; Iacoviello L; de Gaetano G
    Br J Nutr; 2020 Jan; 123(2):190-197. PubMed ID: 31554528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
    Izadi F; Farrokhzad A; Tamizifar B; Tarrahi MJ; Entezari MH
    Phytother Res; 2021 Jan; 35(1):477-485. PubMed ID: 32909326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
    Namkhah Z; Naeini F; Mahdi Rezayat S; Mehdi Yaseri ; Mansouri S; Javad Hosseinzadeh-Attar M
    Int J Clin Pract; 2021 Nov; 75(11):e14852. PubMed ID: 34516703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease.
    Saadati S; Hatami B; Yari Z; Shahrbaf MA; Eghtesad S; Mansour A; Poustchi H; Hedayati M; Aghajanpoor-Pasha M; Sadeghi A; Hekmatdoost A
    Eur J Clin Nutr; 2019 Mar; 73(3):441-449. PubMed ID: 30610213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
    Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
    Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of fermented garlic extract on hepatic function in adults with elevated serum gamma-glutamyl transpeptidase levels: a double-blind, randomized, placebo-controlled trial.
    Kim HN; Kang SG; Roh YK; Choi MK; Song SW
    Eur J Nutr; 2017 Aug; 56(5):1993-2002. PubMed ID: 27743130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between 25-hydroxyvitamin D concentration and liver enzymes in overweight or obese adults: Cross-sectional and interventional outcomes.
    Naderpoor N; Mousa A; de Courten M; Scragg R; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():193-199. PubMed ID: 28899715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial.
    Hosseinabadi S; Rafraf M; Asghari S; Asghari-Jafarabadi M; Vojouhi S
    Complement Ther Med; 2020 Mar; 49():102290. PubMed ID: 32147076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial.
    Khonche A; Huseini HF; Gholamian M; Mohtashami R; Nabati F; Kianbakht S
    J Ethnopharmacol; 2019 Apr; 234():106-111. PubMed ID: 30639231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease.
    Shin HK; Park JH; Yu JH; Jin YJ; Suh YJ; Lee JW; Kim W;
    Sci Rep; 2021 Sep; 11(1):18004. PubMed ID: 34504179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl Ester Transfer Protein Variant (RS1800777) with Liver Histology in Non-Alcoholic Fatty Liver Disease Patients.
    Aller R; Izaola O; Primo D; de Luis D
    Ann Nutr Metab; 2018; 73(4):265-270. PubMed ID: 30293065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Sangouni AA; Nadjarzadeh A; Rohani FS; Sharuni F; Zare Z; Rahimpour S; Hojjat H; Hosseinzadeh M
    Eur J Nutr; 2024 Feb; 63(1):95-105. PubMed ID: 37855891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.